Showing results (11-20 of 261) with videos related to
Sort By:
Pageof 27
The Journal of Antimicrobial Chemotherapy|April 27, 2020
HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial designÁngel Bayón-Gil, Maria C Puertas, Víctor Urrea, et al.Journal of Translational Medicine|February 26, 2013
Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptionsAnuska Llano, Jorge Carrillo, Beatriz Mothe, et al.The Journal of Antimicrobial Chemotherapy|July 27, 2014
Increased expression of SAMHD1 in a subset of HIV-1 elite controllersEva Riveira-Muñoz, Alba Ruiz, Eduardo Pauls, et al.Frontiers in Immunology|December 5, 2022
Disruption of the HLA-E/NKG2X axis is associated with uncontrolled HIV infectionsLuis Romero-Martín, Clara Duran-Castells, Mireia Olivella, et al.AIDS (London, England)|September 28, 2016
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)Alberto C Guardo, Patrick Tjok Joe, Laia Miralles, et al.Immunobiology|February 16, 2012
Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individualsEster Ballana, Alba Ruiz-de Andres, Beatriz Mothe, et al.Cell Research|July 11, 2012
Mechanisms involved in the Abacavir-mediated hypersensitivity syndromeAnuska Llano, Christian BranderCurrent Infectious Disease Reports|February 28, 2007
HIV viral diversity and escape from cellular immunityNicole Frahm, Christian BranderFrontiers in Immunology|February 24, 2018
Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy <i>In Vitro</i>Alex Olvera, Javier P Martinez, Maria Casadellà, et al.Trials|June 19, 2019
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapyWesley de Jong, Joeri Aerts, Sabine Allard, et al.Pageof 27